feed,title,long_url,short_url
Yahoo,Bluebird Bio shares slide 34% after company suspends trials of sickle cell disease treatment,https://www.marketwatch.com/story/bluebird-bio-shares-slide-34-after-company-suspends-trials-of-sickle-cell-disease-treatment-2021-02-16?siteid=yhoof2&yptr=yahoo,https://on.mktw.net/3rXidzF
